Presently, the female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Nicaragua stands at 12%, an increase of 0.7% (6.2%) since 2020.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Nicaragua
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,975
Measure:
%
More indicators for Nicaragua
Out-of-pocket expenditure PPP per capita
intl dollar227
+intl dollar35
(2022)
Newborns protected against tetanus
90%
-2%
(2023)
Female wasting in children
2.1%
+0.7%
(2012)
Birth registration
84.7%
+3.7%
(2012)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
77.4%
+7.6%
(2012)
Nicaragua Female CVD, cancer, diabetes or CRD between 2000 and 2021
Period | Value | Change |
---|---|---|
2021 | 12% | +0.7% |
2020 | 11.3% | -1.1% |
2019 | 12.4% | -0.2% |
2018 | 12.6% | -0.5% |
2017 | 13.1% | -0.2% |
2016 | 13.3% | +0.7% |
2015 | 12.6% | -1.1% |
2014 | 13.7% | +0.7% |
2013 | 13% | -0.6% |
2012 | 13.6% | +0.1% |
2011 | 13.5% | +0.1% |
2010 | 13.4% | -0.3% |
2009 | 13.7% | 0% |
2008 | 13.7% | +0.3% |
2007 | 13.4% | +0.8% |
2006 | 12.6% | -1.4% |
2005 | 14% | 0% |
2004 | 14% | +0.5% |
2003 | 13.5% | -0.4% |
2002 | 13.9% | +0.5% |
2001 | 13.4% | +0.3% |
2000 | 13.1% |